or Try an Advanced Search...

    Technical Analysis for SONN - SONNET BioTherapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.93 -0.80% -0.01
    SONN closed down 0.8 percent on Monday, July 1, 2024, on 19 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical SONN trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.80%
    Calm After Storm Range Contraction -0.80%
    Narrow Range Bar Range Contraction -0.80%
    Wide Bands Range Expansion -0.80%
    Oversold Stochastic Weakness -0.80%
    Older End-of-Day Signals for SONN ...

       Recent Intraday Alerts

    Alert Time
    Down 1% about 8 hours ago
    60 Minute Opening Range Breakdown 3 days ago
    Rose Above Previous Day's High 3 days ago
    Down 2 % 3 days ago
    Down 1% 3 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    SONN Chart by TradingView
    Basic chart:

    Profile

    SONNET BioTherapeutics, Inc. is a biotechnology company that engages in development of bi and tri functional therapies that can simulate or block immune-modulating targets to control cancer. The company uses albumin binding single chain antibody fragment (scFv) for delivery of recombinant human-cytokines (rH-cytokines) and other validated targets. SONNET BioTherapeutics, Inc. was incorporated in 2015 and is based in Princeton, New Jersey.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Biology Immunology Antibody Cytokine Blood Plasma Biochemistry

    Is SONN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 20 Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Jun 20 Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross Proceeds
    Jun 13 Sonnet BioTherapeutics Announces the Generation and Characterization of Two Novel Immunotherapeutic Pipeline Drug Candidates, SON-1411 and SON-1400, Each Containing a Variant IL-18 Domain
    May 28 Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting
    May 22 Sonnet BioTherapeutics Announces Review of Strategic Alternatives
    May 20 Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 as Monotherapy or Combined with an anti-PD-L1, along with an Increase in the Dose-Escalation Target
    May 6 Sonnet BioTherapeutics Announces Participation in the EF Hutton Annual Global Conference
    Mar 11 Sonnet BioTherapeutics Announces Early Safety Data from the Company’s Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Met the Study’s Initial Pre-Specified Objective
    Feb 29 Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers
    Feb 14 Sonnet BioTherapeutics GAAP EPS of -$0.31, revenue of $18.63M
    See more SONN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.4422
    52 Week Low 0.8705
    Average Volume 37,173
    200-Day Moving Average 1.78
    50-Day Moving Average 1.61
    20-Day Moving Average 1.39
    10-Day Moving Average 1.07
    Average True Range 0.13
    RSI (14) 25.93
    ADX 27.98
    +DI 13.86
    -DI 35.57
    Chandelier Exit (Long, 3 ATRs) 1.62
    Chandelier Exit (Short, 3 ATRs) 1.25
    Upper Bollinger Bands 2.14
    Lower Bollinger Band 0.65
    Percent B (%b) 0.19
    BandWidth 107.39
    MACD Line -0.22
    MACD Signal Line -0.17
    MACD Histogram -0.0552
    Fundamentals Value
    Market Cap 2.85 Million
    Num Shares 3.07 Million
    EPS -18.14
    Price-to-Earnings (P/E) Ratio -0.05
    Price-to-Sales 29.80
    Price-to-Book 19.07
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.96
    Resistance 3 (R3) 0.96 0.95 0.96
    Resistance 2 (R2) 0.95 0.94 0.95 0.96
    Resistance 1 (R1) 0.94 0.94 0.94 0.94 0.95
    Pivot Point 0.93 0.93 0.93 0.93 0.93
    Support 1 (S1) 0.92 0.92 0.91 0.92 0.91
    Support 2 (S2) 0.91 0.92 0.91 0.90
    Support 3 (S3) 0.90 0.91 0.90
    Support 4 (S4) 0.90